Floatz logo

CART22-65s

B Cell Leukemias

University of PennsylvaniaPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the B Cell Leukemias cohort.

Asset / SponsorPhaseRating
Cart22 Cells
University of Pennsylvania
Phase 1CC

Same molecule, other indications

CART22-65s is also rated in:

Astrocytic TumorsDormant
CC
Indicative ·
47 / 100
View asset →
Prostate NeoplasmsDormant
CC
Indicative ·
47 / 100
View asset →
Glioblastoma MultiformeDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →